Three Independent Proxy Advisory Firms Support Stockholder Nominees in Amylin Proxy Fight

NEW YORK, May 20 /PRNewswire/ -- Carl C. Icahn announced today that three influential independent proxy voting advisory services, RiskMetrics Group, Glass Lewis & Co and PROXY Governance, Inc., have recommended that stockholders of Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) support stockho...

Icahn Issues Open Letter to Amylin Shareholders

NEW YORK, May 14 /PRNewswire-FirstCall/ -- Carl Icahn announced today that he issued the following open letter to shareholders of Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ). May 14, 2009 Dear Fellow Amylin Shareholders: Amylin's May 11, 2009 letter to shareholders represents a ...

Letter From Carl Icahn to Amylin Pharmaceutical, Inc.

NEW YORK, April 15 /PRNewswire/ -- Carl Icahn announced today that he had sent the following letter to Joseph C. Cook, Jr., Chairman of the Board of Amylin Pharmaceutical, Inc. (Nasdaq: AMLN ) concerning the election of directors to take place at the forthcoming annual meeting of Amylin's...

Lilly and Amylin Set Date and Time for Conference Call

Companies Will Discuss Recent FDA Advisory Regarding Byetta INDIANAPOLIS, Aug. 25 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) and Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) will host a conference call on Tuesday, August 26, 2008 at 5:00 p.m. EDT to discuss the recent...

Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals

BRISBANE, Australia, Nov. 27 /PRNewswire/ -- Xenome Ltd., a leader in developing unique peptides for therapeutic applications in a variety of diseases, today announced the signing of a joint research collaboration agreement with Amylin Pharmaceuticals, Inc. The partnership will focus on the di...

Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance

...tment of NSCLC. The company and its partners amylin Pharmaceuticals, Inc., and Alkermes, Inc. submitte...les of Byetta pen delivery devices to its partner, amylin Pharmaceuticals. For the second quarter, Lilly rec...exed, Lilly) Byetta((R)) (exenatide injection, amylin Pharmaceuticals) Cialis((R)) (tadalafil, Lilly...

Amylin Pharmaceuticals Reports Second Quarter Financial Results

... SAN DIEGO, July 21 /PRNewswire-FirstCall/ -- amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today repo... president of finance and chief financial officer, amylin Pharmaceuticals. "In the last few quarters, we imp...Bradbury, president and chief executive officer at amylin Pharmaceuticals. "Additionally, we created a speci...

Michael J. Fox Foundation Awards $3.8 Million To Drive Nine Industry Partnerships For Pre-Clinical Parkinson's Drug Development

... Pre-clinical development of a Parkinson's disease therapy using a glucagon-like peptide (GLP-1) receptor agonist Kevin Tomaselli, PhD, amylin Pharmaceuticals, Inc., San Diego, California Symptomatic Approaches/Complications of Treatment Effect of novel neuronal nicoton...

Diabetes Drug Byetta May Aid Weight Loss in Obese Patients

...at the annual meeting of the Endocrine Society in Washington, D.C. Previous research has shown that exenatide, an injectable medication marketed by amylin Pharmaceuticals and Eli Lilly and Company under the brand name Byetta, can help lower blood sugar and helps some diabetics lose weight. The current st...

Use of Mealtime Pramlintide Added to Basal Insulin Showed Similar Improvements in Glycemic Control Compared to Rapid-Acting Insulin, With Lower Risk of Hypoglycemia and Without Weight Gain: Data Presented at ADA 2009

... NEW ORLEANS, June 6 /PRNewswire-FirstCall/ -- amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today anno... Taken at mealtime, SYMLIN is the first and only amylin mimetic for use in patients with diabetes treated ...resulting in reduced secretion of both insulin and amylin after meals. The use of SYMLIN contributes to gluc...

Amylin in Medical Technology

Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study

...BRIDGE, Mass., July 20 /PRNewswire-FirstCall/ -- amylin Pharmaceuticals, Inc., (Nasdaq: AMLN ), Eli Lill...senior vice president of research and development, amylin Pharmaceuticals. "Both treatment arms started with...tly approved by any regulatory agencies. amylin Pharmaceuticals is a biopharmaceutical company com...

Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009

... NEW ORLEANS, June 8 /PRNewswire-FirstCall/ -- amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) and Eli Li...ent." "Patient safety is of utmost concern at amylin and Lilly," said Orville G. Kolterman, M.D., senio... information, visit www.BYETTA.com . About amylin and Lilly ...

Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009

... NEW ORLEANS, June 7 /PRNewswire-FirstCall/ -- amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ), Eli Lilly...rrently approved by any regulatory agencies. amylin Pharmaceuticals is a biopharmaceutical company com...potential therapies to treat diabetes and obesity. amylin is headquartered in San Diego, California. T...

Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly

...d INDIANAPOLIS, April 29 /PRNewswire-FirstCall/ -- amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) and Eli Li... Exenatide Once Weekly Pen Supply Agreement amylin and Lilly have agreed in principle to cooperate in...pproximately $216 million over the next few years. amylin and Lilly have agreed that the cost of the initial...

Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study

...MBRIDGE, Mass., March 31 /PRNewswire-FirstCall/ -- amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ), Eli Lilly...nior vice president of research and development at amylin Pharmaceuticals. "These data continue to build the...rrently approved by any regulatory agencies. amylin Pharmaceuticals is a biopharmaceutical company com...

Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback

...e once weekly is not currently approved by any regulatory agencies. amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives...in metabolism to develop potential therapies to treat diabetes and obesity. amylin is headquartered in San Diego, California. Through a long-standing ...

Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society

...rapy SAN DIEGO, Oct. 1 /PRNewswire-FirstCall/ -- amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today annou... scientific conferences in the field of obesity. amylin will present scientific data through 11 oral and p...Bradbury, president and chief executive officer at amylin Pharmaceuticals, Inc. "Our unique neurohormonal ap...

After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008

... SAN FRANCISCO, June 9 /PRNewswire-FirstCall/ -- amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ), Eli Lilly ...t currently approved by any regulatory agencies. amylin Pharmaceuticals is a biopharmaceutical company com...ent and commercialization of innovative medicines. amylin has developed and gained approval for two first-in...

Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin

... SAN FRANCISCO, June 9 /PRNewswire-FirstCall/ -- amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today annou... suggest that treating a deficiency of the hormone amylin in type 2 diabetes can have a beneficial effect on... Taken at mealtime, SYMLIN is the first and only amylin mimetic for use in patients with diabetes treated ...

Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight

... SAN FRANCISCO, June 7 /PRNewswire-FirstCall/ -- amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ), Eli Lilly ...t currently approved by any regulatory agencies. amylin Pharmaceuticals is a biopharmaceutical company com...ent and commercialization of innovative medicines. amylin has developed and gained approval for two first- i...

Amylin in Biological News

UC San Diego senior named Churchill Scholar for extraordinary undergraduate research

...ked full-time at the UC San Diego School of Medicine with the support of an amylin Research Scholarship, which is funded through amylin Pharmaceutical's support of the Chancellor's Challenge 5K Run/Walk for Scho...

Bees, Brains and Addiction

...through a neuroscience educational outreach program called "Grey Matters," initiated last fall by UCSD's Division of Biological Sciences and funded by amylin Pharmaceuticals. The program includes a monthly lay language lecture by a local neuroscientist on a topic of broad public interest, televised broad...

FDA Approves New Drug to Treat Type I and Type II Diabetes

... vomiting, abdominal pain, headache, fatigue and dizziness. Symlin has not been evaluated in the pediatric population. Symlin is manufactured by amylin Pharmaceuticals, Inc. of San Diego, California. ...

Amylin in Biological Technology

Icahn Asks Amylin to Allow Discussions With Eastbourne

NEW YORK, April 23 /PRNewswire/ -- Carl Icahn announced today that he had sent the following letter to James Wilson, Lead Independent Director of Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ). April 23, 2009 Mr. James Wilson Lead Independent...

Lilly and Amylin Enter Into Supply Agreement for Exenatide Once Weekly

Lilly to Pay Amylin $125 Million and Extend $165 Million Line of Credit to Amylin SAN DIEGO and INDIANAPOLIS, Oct. 21 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) and Eli Lilly and Company (NYSE: LLY ) today announced they have entered...

Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners

BRISBANE, Australia, Nov. 27 /PRNewswire/ -- Xenome Ltd, a specialist biopharmaceutical company developing novel peptide drugs, announced today that it has successfully raised US$10M of equity finance. The syndicated funding round includes continuing support from Xenome's major investor, Queen...

Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIG's Plenary Panel in Vegas

NEW YORK, Sept. 17 /PRNewswire/ -- iiBIG's New Directions for Drug Delivery: Emerging Modes, Novel Science and Profitable Deal Strategies conference is scheduled for October 29-30, 2007, at the Flamingo in Las Vegas, Nevada. The sessions will cover developments in controlled release technologi...

Amylin Pharmaceuticals to Webcast Second Quarter Results

... SAN DIEGO, July 14 /PRNewswire-FirstCall/ -- amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) will webca... will lead the call. On the same date post-market, amylin will release financial results for the second quar...national), Conference ID# 67467542. About amylin ...

Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment for Obesity

... SAN DIEGO, July 9 /PRNewswire-FirstCall/ -- amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today anno...nt, corporate development, diabetes and obesity at amylin Pharmaceuticals. "Our integrated neurohormonal app...rain) to uncover their full therapeutic potential. amylin scientists discovered that combination treatment w...

New Drug Application for Exenatide Once Weekly Accepted for Review by FDA

...MBRIDGE, Mass., July 7 /PRNewswire-FirstCall/ -- amylin Pharmaceuticals, Inc., (Nasdaq: AMLN ), Eli Lill...nior vice president of research and development at amylin Pharmaceuticals. "If approved, this therapy could ...rrently approved by any regulatory agencies. amylin Pharmaceuticals is a biopharmaceutical company com...

Paulo F. Costa Joins MacroGenics Board of Directors

...m Harvard Business School and is a graduate of the Sao Paulo School of Business Administration. Mr. Costa recently joined the Board of Directors of amylin Pharmaceuticals, Inc. One current director, John Maraganore, Ph.D., has retired from the Board of Directors of MacroGenics. "We greatly apprecia...

Amylin Pharmaceuticals to Present at Piper Jaffray Europe Conference

... SAN DIEGO, June 17 /PRNewswire-FirstCall/ -- amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be pr...Bradbury, president and chief executive officer of amylin Pharmaceuticals, will provide a corporate overview...download any necessary audio software. About amylin Pharmaceuticals ...

Amylin Pharmaceuticals to Present at Goldman Sachs Annual Global Health Care Conference

... SAN DIEGO, June 3 /PRNewswire-FirstCall/ -- amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be pr...Bradbury, president and chief executive officer of amylin Pharmaceuticals, will provide a corporate overview...download any necessary audio software. About amylin Pharmaceuticals ...

Amylin in Biological Dictionary

Peptides

...tic cells that may represent... Bio-Synthesis Inc. is a leading life science products company which deals in Custom Peptide Synthesis, Services amylin Peptides , Trojan Peptides , Oxygen Peptide , ... Peptides International manufactures and distributes biochemical products for major researc...

Peptide

...d control the amount of sugar ... Bio-Synthesis Inc. is a leading life science products company which deals in Custom Peptide Synthesis, Services amylin Peptides , Trojan Peptides , Oxygen Peptide , ... Custom DNA, peptides , and molecular biology products. Medical information about Diabete...